Home › Compare › EQRXW vs YUM

EQRXW vs YUM: Dividend Comparison 2026

EQRXW yields 4395.60% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQRXW wins by $17844003331689.93M in total portfolio value
10 years
EQRXW
EQRXW
● Live price
4395.60%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17844003331690.04M
Annual income
$17,079,643,292,413,290,000.00
Full EQRXW calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — EQRXW vs YUM

📍 EQRXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEQRXWYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EQRXW + YUM cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EQRXW pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EQRXW
Annual income on $10K today (after 15% tax)
$373,626.37/yr
After 10yr DRIP, annual income (after tax)
$14,517,696,798,551,296,000.00/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, EQRXW beats the other by $14,517,696,798,551,261,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EQRXW + YUM for your $10,000?

EQRXW: 50%YUM: 50%
100% YUM50/50100% EQRXW
Portfolio after 10yr
$8922001665845.07M
Annual income
$8,539,821,646,206,666,000.00/yr
Blended yield
95.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

EQRXW
No analyst data
Altman Z
9.5
Piotroski
1/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EQRXW buys
0
YUM buys
0
No recent congressional trades found for EQRXW or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEQRXWYUM
Forward yield4395.60% ✓1.85%
Annual dividend / share$2.00$2.88 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4% ✓
Portfolio after 10y$17844003331690.04M ✓$107.0K
Annual income after 10y$17,079,643,292,413,290,000.00 ✓$39,957.33
Total dividends collected$17792054110403.60M ✓$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: EQRXW vs YUM ($10,000, DRIP)

YearEQRXW PortfolioEQRXW Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$450,260$439,560.44$10,980$280.44+$439.3K → EQRXW
2$18,978,664$18,496,885.68$12,185$435.72+$18.97M → EQRXW
3$748,953,345$728,646,173.66$13,722$684.14+$748.94M → EQRXW
4$27,674,743,815$26,873,363,736.79$15,773$1,090.14+$27674.73M → EQRXW
5$957,652,835,286$928,040,859,403.20$18,650$1,773.02+$957652.82M → EQRXW
6$31,037,578,041,538$30,012,889,507,782.54$22,921$2,966.37+$31037578.02M → EQRXW
7$942,293,671,101,243$909,083,462,596,797.50$29,685$5,158.69+$942293671.07M → EQRXW
8$26,802,238,424,024,828$25,793,984,195,946,500.00$41,216$9,453.02+$26802238423.98M → EQRXW
9$714,355,176,894,161,700$685,676,781,780,455,000.00$62,672$18,571.31+$714355176894.10M → EQRXW
10$17,844,003,331,690,041,000$17,079,643,292,413,290,000.00$107,016$39,957.33+$17844003331689.93M → EQRXW

EQRXW vs YUM: Complete Analysis 2026

EQRXW — Stock

EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. Its product pipeline in development includes Aumolertinib, an EGFR inhibitor for the treatment of ?EGFR-mutated? non-small cell lung cancer (NSCLC); Sugemalimab, an anti-PD-L1 antibody for the treatment of ?stage III and IV ?NSCLC; Lerociclib, a CDK4/6 inhibitor to treat HR+/HER2- breast cancer; and EQ176, an anti-PD-1?antibody for the treatment of liver cancer. The company has partnerships with Exscientia and AbCellera Biologics Inc. EQRx, Inc. was founded in 2020 and is based in Cambridge, Massachusetts.

Full EQRXW Calculator →

YUM — Consumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this EQRXW vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EQRXW vs SCHDEQRXW vs JEPIEQRXW vs OEQRXW vs KOEQRXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.